SMTL ID : 3ldx.1

Discovery and Clinical Evaluation of RWJ-671818, a Thrombin Inhibitor with an Oxyguanidine P1 Motif

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.25 Å

Oligo State

hetero-oligomer

Ligands

1 x NLI: N-[2-(carbamimidamidooxy)ethyl]-2-{3-[(2,2-difluoro-2-phenylethyl)amino]-6-methyl-2-oxopyrazin-1(2H)-yl}acetamide(Non-covalent)

NLI.1: 16 residues within 4Å: Chain B: H.43, Y.47, W.50, E.94, L.96, D.199, A.200, C.201, S.205, V.225, S.226, W.227, G.228, E.229, G.230, G.238 12 PLIP interactions: 12 interactions with chain B Hydrophobic interactions: B:Y.47, B:L.96, B:L.96, B:W.227 Hydrogen bonds: B:A.200, B:S.226, B:G.228, B:G.228, B:G.230 Water bridges: B:S.226, B:F.239 Salt bridges: B:D.199

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Spurlino, J.C., Discovery and Clinical Evaluation of RWJ-671818, a Thrombin Inhibitor with an Oxyguanidine P1 Motif. To be Published

Release Date

2011-08-10

Peptides

Thrombin light chain: A
Thrombin heavy chain: B
Hirudin variant-1: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
L

B
H

C
I

Thrombin light chain

Thrombin heavy chain

Hirudin variant-1

Related Entries With Identical Sequence